FY2025 · ended Dec 31, 2025 · Revenue $1.42B, +13.9% YoY · Filed Feb 25, 2026
LifeStance Health Group, Inc. (LFST) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 billion and net income of $9.7 million. Free cash flow was $110.0 million. As of Sep 30, 2026 it held $218.8 million in cash and investments and $477.4 million in total debt.
Revenue (TTM)
$1.68B
+22.6% vs year-ago TTM
Net income (TTM)
$71.91M
+888.7% vs year-ago TTM
Operating cash flow (TTM)
$227.60M
+50.8% vs year-ago TTM
Free cash flow (TTM)
$179.27M
+50.2% vs year-ago TTM
EPS (TTM)
$0.18
+867.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
389.78M
+1.4% vs prior year
Net cash
$-258.55M
as of Sep 30, 2026
Operating margin
6.2%
FY 2026
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- LFST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Scottsdale, AZ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1845257
Other Services-Health Services companies
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- U S Physical Therapy Inc /NV USPH
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.1B | $859.5M | $667.5M |
| Operating income | $24.1M | -$31.6M | -$189.1M | -$210.2M | -$286.4M |
| Net income | $9.7M | -$57.4M | -$186.3M | -$215.6M | -$307.2M |
| Operating cash flow | $146.2M | $107.3M | -$16.9M | $52.8M | $9.4M |
| Free cash flow | $110.0M | $85.7M | -$57.4M | -$26.5M | -$85.1M |
| Total assets | $2.2B | $2.1B | $2.1B | $2.2B | $1.9B |
| Total liabilities | $682.9M | $672.0M | $681.0M | $655.1M | $382.1M |
| Stockholders' equity | $1.5B | $1.4B | $1.4B | $1.5B | $1.5B |
| Cash and investments | $248.6M | $154.6M | $78.8M | $108.6M | $148.0M |
| Total debt | $476.8M | $488.1M | $517.3M | $485.4M | $161.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 11, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
All 502 LifeStance Health Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.